The JAMA Network

JAMA.20K;31t(5);5O7-52O. dOi:IO.t001.|ama.2013 28-M2?

20H Hypertension Cii,.,i.>li:ifi '.Viiv/jiincut AlgoirtJunSBP indicates Systolic blood piangiotensin-camfiningenzyme; ARB.BngtotMldn pBC4j%H MOCfcw; and CCB, calcil

: Report From the

New Endocrine Drugs

Empagliflozin and Lingagliptin(Glyxambi®)• Combination sodium-glucose co-

transporter 2 (SGLT2) inhibitor anddipeptidyl peptidase-4 (DPP-4) inhibitor

• Indication:

- Adjunct to diet and exercise to improveglycemic control in adults with type 2diabetes

- Not for treatment of type 1 DM

- Has not been studied in patients with hx ofpancreatitis *.